France - McDermott Will & Emery



France is a key player on the global stage—economically, politically and culturally. It offers ample opportunities for both national and international businesses to innovate, expand and pursue their business vision. Whether you are seeking to strengthen your position in France or around the world, we are here to help.

We know that you face myriad challenges every day, which is why our purpose-built teams of multilingual lawyers deliver sophisticated yet practical advice to help you achieve your goals. Our 80-lawyer Paris team offers cross-disciplinary counsel in all key areas of law, including corporate transactions, EU competition, finance, labor and employment, litigation and dispute resolution, private equity, public law, tax and intellectual property. We partner with some of the region’s best-known companies as well as multinational investors, corporates and financial institutions seeking to enter the French marketplace.

Whatever industry your business operates in, we draw on our extensive sector knowledge to offer the legal insights you need to succeed. Our lawyers offer particularly deep experience in fields such as life sciences, construction and engineering, distribution, energy, oil and gas, telecommunications and transportation. We guide privately held, publicly traded and state-owned enterprises through the laws and regulations governing foreign investments in France, and deploy our thorough understanding of global business practices to negotiate common ground and close deals quickly.

Over the last ten years we have been privileged to fuel the missions of key market players in France; breaking down barriers to client success. Our thanks to our clients for your continued trust, and to our alumni for your continued engagement as we celebrate our ten year anniversary in Paris.

Show More


  • Mitsubishi Heavy Industries on its offer to create a partnership with Alstom in the energy field in the form of a joint venture including Alstom’s energy assets, steam turbines, hydro and grid businesses
  • Mitsubishi Heavy Industries Ltd in its potential investment in Areva NP, a reactor unit of French nuclear giant Areva SA
  • Servier, a French pharmaceutical laboratory, within the framework of the exclusive worldwide licensing option with Cellectis for UCART19, and its strategic agreement with Pfizer
  • Servier on its strategic partnership with Intarcia Therapeutics, Inc., to develop and commercialize ITCA 650, Intarcia’s phase-3 investigational therapies for the treatment of type-2 diabetes, outside the United States and Japan—one of the largest biotechnology partnership agreements outside the United States
  • DBV Technologies, S.A., a clinical-stage biopharmaceutical company focused on changing the field of immunotherapy, with its US$281.5 million public offering (approximately EUR 255 million) of new shares in the form of American Depositary Shares

Show More


A diverse, global network of industry-leading talent committed to you and your vision.